{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:54:09Z","timestamp":1793760849048,"version":"4.6.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","aaojournal.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ophtha.2018.03.013","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T08:31:05Z","timestamp":1523349065000},"page":"1459-1467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Chemodenervation for the Treatment of Facial Dystonia"],"prefix":"10.1016","volume":"125","author":[{"given":"Jurij R.","family":"Bilyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Wladis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A.","family":"Mawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ophtha.2018.03.013_bib1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"87","author":"Scott","year":"1980","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2018.03.013_bib2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/eye.2009.192","article-title":"Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes","volume":"24","author":"Cillino","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2018.03.013_bib3","article-title":"Conversion ratio between Botox(\u00ae), Dysport(\u00ae), and Xeomin(\u00ae) in clinical practice","volume":"865","author":"Scaglione","year":"2016","journal-title":"Toxins (Basel)"},{"issue":"6","key":"10.1016\/j.ophtha.2018.03.013_bib4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","article-title":"DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A\u2014Dysport and Botox\u2014assuming a ratio of 4:1","volume":"12","author":"Sampaio","year":"1997","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ophtha.2018.03.013_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/mdc3.12235","article-title":"OnabotulinumtoxinA and AbobotulinumtoxinA dose conversion: a systematic literature review","volume":"3","author":"Dashtipour","year":"2016","journal-title":"Mov Disord Clin Pract"},{"issue":"suppl 2","key":"10.1016\/j.ophtha.2018.03.013_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2009.02880.x","article-title":"Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm","volume":"16","author":"Jankovic","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ophtha.2018.03.013_bib7","unstructured":"Oxford Centre for Evidence-Based Medicine. Levels of evidence (March 2009). http:\/\/www.cebm.net\/index.aspx?o=1025; Accessed 24.08.17."},{"issue":"5","key":"10.1016\/j.ophtha.2018.03.013_bib8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/sj.eye.6700444","article-title":"A\u00a0new grading system for assessing orbicularis muscle function","volume":"17","author":"Rahman","year":"2003","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.ophtha.2018.03.013_bib9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ophtha.2018.03.013_bib10","first-page":"424","article-title":"Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid force","volume":"39","author":"Iwashige","year":"1995","journal-title":"Jpn J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2018.03.013_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/mds.25579","article-title":"Dystonia rating scales: critique and recommendations","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.ophtha.2018.03.013_bib12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00702-010-0546-9","article-title":"Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm","volume":"118","author":"Wabbels","year":"2011","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"3","key":"10.1016\/j.ophtha.2018.03.013_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.22368","article-title":"Relationship between various clinical outcome assessments in patients with blepharospasm","volume":"24","author":"Jankovic","year":"2009","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ophtha.2018.03.013_bib14","first-page":"5","article-title":"The management of blepharospasm and hemifacial spasm","volume":"239","author":"Elston","year":"1992","journal-title":"J\u00a0Neurol"},{"issue":"7","key":"10.1016\/j.ophtha.2018.03.013_bib15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mus.880180708","article-title":"Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin","volume":"18","author":"Van den Bergh","year":"1995","journal-title":"Muscle Nerve"},{"issue":"suppl 1","key":"10.1016\/j.ophtha.2018.03.013_bib16","first-page":"21","article-title":"Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm","volume":"248","author":"Jost","year":"2001","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.ophtha.2018.03.013_bib17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archneur.59.3.418","article-title":"Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study","volume":"59","author":"Defazio","year":"2002","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.ophtha.2018.03.013_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02340723","article-title":"Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group","volume":"14","author":"Berardelli","year":"1993","journal-title":"Ital J Neurol Sci"},{"issue":"3-A","key":"10.1016\/j.ophtha.2018.03.013_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1590\/S0004-282X1995000300006","article-title":"Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients [in Portuguese]","volume":"53","author":"Novis","year":"1995","journal-title":"Arq Neuropsiquiatr"},{"issue":"5","key":"10.1016\/j.ophtha.2018.03.013_bib20","first-page":"210","article-title":"Focal dystonias and facial hemispasm: treatment with botulinum A toxin","volume":"54","author":"Astarloa","year":"1991","journal-title":"Arch Neurobiol (Madr)"},{"issue":"5","key":"10.1016\/j.ophtha.2018.03.013_bib21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3346\/jkms.1993.8.5.334","article-title":"Botulinum A toxin treatment of hemifacial spasm and blepharospasm","volume":"8","author":"Park","year":"1993","journal-title":"J\u00a0Korean Med Sci"},{"issue":"5","key":"10.1016\/j.ophtha.2018.03.013_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2007.11.003","article-title":"Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial","volume":"14","author":"Truong","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"10.1016\/j.ophtha.2018.03.013_bib23","first-page":"1205","article-title":"Hemifacial spasm: results of treatment with low dose botulinum toxin injection","volume":"87","author":"Suputtitada","year":"2004","journal-title":"J\u00a0Med Assoc Thai"},{"issue":"6","key":"10.1016\/j.ophtha.2018.03.013_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jnnp.60.6.693-a","article-title":"Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients","volume":"60","author":"Albanese","year":"1996","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ophtha.2018.03.013_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/jnnp.63.4.556","article-title":"Pretarsal injections of botulinum toxin improve blephospasm in previously unresponsive patients","volume":"63","author":"Kowal","year":"1997","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ophtha.2018.03.013_bib26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jnnp.60.6.704","article-title":"Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening","volume":"60","author":"Jankovic","year":"1996","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ophtha.2018.03.013_bib27","first-page":"64","article-title":"Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm","volume":"249","author":"\u00c7akmur","year":"2002","journal-title":"J\u00a0Neurol"},{"issue":"suppl 3","key":"10.1016\/j.ophtha.2018.03.013_bib28","first-page":"S48","article-title":"Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study","volume":"95","author":"Kongsengdao","year":"2012","journal-title":"J\u00a0Med Assoc Thai"},{"issue":"8","key":"10.1016\/j.ophtha.2018.03.013_bib29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/mds.20468","article-title":"Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study","volume":"20","author":"Marchetti","year":"2005","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ophtha.2018.03.013_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2340\/16501977-1895","article-title":"Switch from abobotulinumtoxinA (Dysport(R)) to incobotulinumtoxinA (Xeomin(R)) botulinum toxin formulation: a review of 257 cases","volume":"47","author":"Grosset","year":"2015","journal-title":"J\u00a0Rehabil Med"},{"issue":"suppl 4","key":"10.1016\/j.ophtha.2018.03.013_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1468-1331.2006.01649.x","article-title":"Using translational medicine to understand clinical differences between botulinum toxin formulations","volume":"13","author":"Aoki","year":"2006","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.ophtha.2018.03.013_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/PL00004951","article-title":"Botulinum A toxins: units versus units","volume":"355","author":"Wohlfarth","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"10.1016\/j.ophtha.2018.03.013_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3341\/kjo.2009.23.3.137","article-title":"Double-blind, randomized, comparative study of Meditoxin versus Botox in the treatment of essential blepharospasm","volume":"23","author":"Yoon","year":"2009","journal-title":"Korean J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2018.03.013_bib34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00702-007-0768-7","article-title":"Botulinum toxin in the treatment of blepharospasm and hemifacial spasm","volume":"115","author":"Kenney","year":"2008","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"4","key":"10.1016\/j.ophtha.2018.03.013_bib35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00941758","article-title":"Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm","volume":"235","author":"N\u00fcssgens","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2018.03.013_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","article-title":"Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm","volume":"113","author":"Roggenk\u00e4mper","year":"2006","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"1","key":"10.1016\/j.ophtha.2018.03.013_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0161-6420(86)33785-0","article-title":"The use of botulinum toxin in the medical management of benign essential blepharospasm","volume":"93","author":"Perman","year":"1986","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2018.03.013_bib38","first-page":"281","article-title":"Treatment of various movement disorders with botulinum A toxin injection: an experience of 900 patients","volume":"78","author":"Poungvarin","year":"1995","journal-title":"J\u00a0Med Assoc Thai"},{"issue":"5","key":"10.1016\/j.ophtha.2018.03.013_bib39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0161-6420(97)30220-6","article-title":"Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections","volume":"104","author":"Price","year":"1997","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ophtha.2018.03.013_bib40","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1590\/S0004-282X2012000900003","article-title":"Clinical features and treatment with botulinum toxin in blepharospasm: a 17-year experience","volume":"70","author":"Aquino","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.ophtha.2018.03.013_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/CEOR.S86355","article-title":"AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis","volume":"7","author":"Abogunrin","year":"2015","journal-title":"Clinicoecon Outcomes Res"},{"issue":"7","key":"10.1016\/j.ophtha.2018.03.013_bib42","doi-asserted-by":"crossref","first-page":"A759","DOI":"10.1016\/j.jval.2015.09.2475","article-title":"Cost-effectiveness of Incobotulinumtoxin-A with flexible treatment intervals compared to Onabotulinumtoxin-A in the management of blepharospasm and cervical dystonia","volume":"18","author":"Tilden","year":"2015","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.ophtha.2018.03.013_bib43","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","article-title":"A\u00a0new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia","volume":"64","author":"Benecke","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ophtha.2018.03.013_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00702-010-0529-x","article-title":"Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm","volume":"118","author":"Wabbels","year":"2011","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"8","key":"10.1016\/j.ophtha.2018.03.013_bib45","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/mds.23658","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial","volume":"26","author":"Jankovic","year":"2011","journal-title":"Mov Disord"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018306870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018306870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T11:08:24Z","timestamp":1534936104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642018306870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0161642018306870"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.03.013","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemodenervation for the Treatment of Facial Dystonia","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}